{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:22Z","timestamp":1793374222418,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Large cardiac rhabdomyomas can disturb hemodynamic flow. Tuberous sclerosis complex is the most common cause of cardiac rhabdomyoma in fetuses. Recently, a mammalian target of rapamycin (mTOR) inhibitor effectively treated rhabdomyomas associated with tuberous sclerosis. Here, we report the effectiveness of an mTOR inhibitor in treating a fetus with large rhabdomyomas exhibiting severe heart failure when administered transplacentally. A 30-year-old pregnant woman was transferred to our hospital due to the presence of a cardiac tumor in the left ventricle (LV) of the fetus, which gradually enlarged to\u2009&gt;\u200940\u00a0mm in diameter. The diastolic and systolic functions of the LV were completely disrupted. At 32\u00a0weeks of gestation, the fetus showed severe heart failure (cardiovascular profile score 7), with a high risk of death. The hemodynamic flow was consistent with hypoplastic left heart syndrome. Fetal magnetic resonance imaging revealed several cranial regions with 7.9\u2009\u00d7\u20096.9\u00a0mm subependymal giant cell astrocytoma (SEGA). The fetus was clinically diagnosed with tuberous sclerosis, and therapy was initiated with maternally administered sirolimus, an mTOR inhibitor. Sirolimus effectively reduced the size of the tumor and improved the hemodynamics of the fetus. No severe complications occurred in the mother or fetus. The baby was born at 39\u00a0weeks of gestation with a mildly reduced LV ejection fraction. In addition, the dimensions of the intracranial SEGA decreased somewhat following initiation of maternal sirolimus treatment. Postnatal genetic testing confirmed a mutation in the\n                    <jats:italic>TSC2<\/jats:italic>\n                    gene. Currently, the baby is 3\u00a0months old with normal neurological development. Transplacental sirolimus administration can be a useful in treating large rhabdomyomas that disturb fetal hemodynamics.\n                  <\/jats:p>","DOI":"10.1186\/s13023-025-03780-7","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T03:40:08Z","timestamp":1749440408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Transplacental sirolimus: a new treatment strategy for life-threatening fetal cardiac rhabdomyomas\u2014a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7762-5039","authenticated-orcid":false,"given":"Kaname","family":"Uno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ebina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"3780_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/pd.2586","volume":"30","author":"K Niewiadomska-Jarosik","year":"2010","unstructured":"Niewiadomska-Jarosik K, Sta\u0144czyk J, Janiak K, Jarosik P, Moll JJ, Zamojska J, et al. Prenatal diagnosis and follow-up of 23 cases of cardiac tumors. Prenat Diagn. 2010;30:882\u20137. https:\/\/doi.org\/10.1002\/pd.2586.","journal-title":"Prenat Diagn"},{"key":"3780_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s002460010071","volume":"21","author":"AE Becker","year":"2000","unstructured":"Becker AE. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatr Cardiol. 2000;21:317\u201323. https:\/\/doi.org\/10.1007\/s002460010071.","journal-title":"Pediatr Cardiol"},{"key":"3780_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2261-14-66","volume":"14","author":"P Sciacca","year":"2014","unstructured":"Sciacca P, Giacchi V, Mattia C, Greco F, Smilari P, Betta P, et al. Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases. BMC Cardiovasc Disord. 2014;14:1\u201311. https:\/\/doi.org\/10.1186\/1471-2261-14-66.","journal-title":"BMC Cardiovasc Disord"},{"key":"3780_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/uog.19108","volume":"54","author":"J Chen","year":"2019","unstructured":"Chen J, Wang J, Sun H, Gu X, Hao X, Fu Y, et al. Fetal cardiac tumor: echocardiography, clinical outcome and genetic analysis in 53 cases. Ultrasound Obstet Gynecol. 2019;54:103\u20139. https:\/\/doi.org\/10.1002\/uog.19108.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3780_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/uog.5264","volume":"31","author":"AS Chao","year":"2008","unstructured":"Chao AS, Chao A, Wang TH, Chang YC, Chang YL, Hsieh CC, et al. Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis. Ultrasound Obstet Gynecol. 2008;31:289\u201395. https:\/\/doi.org\/10.1002\/uog.5264.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3780_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000320483","volume":"29","author":"G De Rosa","year":"2011","unstructured":"De Rosa G, De Carolis MP, Pardeo M, Bersani I, Tempera A, De Nisco A, et al. Neonatal emergencies associated with cardiac rhabdomyomas: an 8-year experience. Fetal Diagn Ther. 2011;29:169\u201377. https:\/\/doi.org\/10.1159\/000320483.","journal-title":"Fetal Diagn Ther"},{"key":"3780_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3174\/ajnr.A7455","volume":"43","author":"SK Goergen","year":"2022","unstructured":"Goergen SK, Fahey MC. Prenatal MR imaging phenotype of fetuses with tuberous sclerosis: an institutional case series and literature review. Am J Neuroradiol. 2022;43:633\u20138. https:\/\/doi.org\/10.3174\/ajnr.A7455.","journal-title":"Am J Neuroradiol"},{"key":"3780_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, Sampson JR, et al. Comprehensive mutation analysis of TSC1 and TSC2\u2014and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet. 1999;64:1305\u201315. https:\/\/doi.org\/10.1086\/302381.","journal-title":"Am J Hum Genet"},{"key":"3780_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pd.6492","volume":"44","author":"S Qaderi","year":"2024","unstructured":"Qaderi S, Javinani A, Blumenfeld YJ, Krispin E, Papanna R, Chervenak FA, et al. Mammalian target of rapamycin inhibitors: a new-possible approach for in-utero medication therapy. Prenat Diagn. 2024;44:88\u201398. https:\/\/doi.org\/10.1002\/pd.6492.","journal-title":"Prenat Diagn"},{"key":"3780_CR10","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske EP, J\u00f3zwiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Prim. 2016;2:16035\u201354. https:\/\/doi.org\/10.1038\/nrdp.2016.35.","journal-title":"Nat Rev Dis Prim"},{"key":"3780_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243\u201354. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.001.","journal-title":"Pediatr Neurol"},{"key":"3780_CR12","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1067\/S0022-3476(03)00494-3","volume":"143","author":"RS Bader","year":"2003","unstructured":"Bader RS, Chitayat D, Kelly E, Ryan G, Smallhorn JF, Toi A, et al. Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex. J Pediatr. 2003;143:620\u20134. https:\/\/doi.org\/10.1067\/S0022-3476(03)00494-3.","journal-title":"J Pediatr"},{"key":"3780_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ped.15219","volume":"64","author":"S Inoue","year":"2022","unstructured":"Inoue S, Inuzuka R, Kakiuchi S, Sato A, Matsui H. Successful treatment with everolimus for severe heart failure with large cardiac rhabdomyomas. Pediatr Int. 2022;64:5\u20137. https:\/\/doi.org\/10.1111\/ped.15219.","journal-title":"Pediatr Int"},{"key":"3780_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1077-6","volume":"14","author":"A Saffari","year":"2019","unstructured":"Saffari A, Br\u00f6sse I, Wiemer-Kruel A, Wilken B, Kreuzaler P, Hahn A, et al. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age\u2014a multicenter retrospective study. Orphanet J Rare Dis. 2019;14:1\u201313. https:\/\/doi.org\/10.1186\/s13023-019-1077-6.","journal-title":"Orphanet J Rare Dis"},{"key":"3780_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.23960","volume":"74","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol. 2013;74:679\u201387. https:\/\/doi.org\/10.1002\/ana.23960.","journal-title":"Ann Neurol"},{"key":"3780_CR16","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388:2153\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(16)31419-2.","journal-title":"Lancet"},{"key":"3780_CR17","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862\u20138. https:\/\/doi.org\/10.1093\/nar\/gkv1222.","journal-title":"Nucleic Acids Res"},{"key":"3780_CR18","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/nejmc1800352","volume":"378","author":"BT Barnes","year":"2018","unstructured":"Barnes BT, Procaccini D, Crino J, Blakemore K, Sekar P, Sagaser KG, et al. Maternal sirolimus therapy for fetal cardiac rhabdomyomas. N Engl J Med. 2018;378:1844\u20135. https:\/\/doi.org\/10.1056\/nejmc1800352.","journal-title":"N Engl J Med"},{"key":"3780_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/pd.5613","volume":"40","author":"ID Pluym","year":"2020","unstructured":"Pluym ID, Sklansky M, Wu JY, Afshar Y, Holliman K, Devore GR, et al. Fetal cardiac rhabdomyomas treated with maternal sirolimus. Prenat Diagn. 2020;40:358\u201364. https:\/\/doi.org\/10.1002\/pd.5613.","journal-title":"Prenat Diagn"},{"key":"3780_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms241612886","volume":"24","author":"A Ma\u00e1sz","year":"2023","unstructured":"Ma\u00e1sz A, Bod\u00f3 T, Till \u00c1, Moln\u00e1r G, Masszi G, Labossa G, et al. Three-year follow-up after intrauterine mTOR inhibitor administration for fetus with TSC-associated rhabdomyoma. Int J Mol Sci. 2023;24:1\u201311. https:\/\/doi.org\/10.3390\/ijms241612886.","journal-title":"Int J Mol Sci"},{"key":"3780_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/uog.20353","volume":"54","author":"LJ Salomon","year":"2019","unstructured":"Salomon LJ, Sotiriadis A, Wulff CB, Odibo A, Akolekar R. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019;54:442\u201351. https:\/\/doi.org\/10.1002\/uog.20353.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3780_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.ejpn.2018.08.005","volume":"22","author":"P Dragoumi","year":"2018","unstructured":"Dragoumi P, O\u2019Callaghan F, Zafeiriou DI. Diagnosis of tuberous sclerosis complex in the fetus. Eur J Paediatr Neurol. 2018;22:1027\u201334. https:\/\/doi.org\/10.1016\/j.ejpn.2018.08.005.","journal-title":"Eur J Paediatr Neurol"},{"key":"3780_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pediatrneurol.2021.09.014","volume":"125","author":"D Ebrahimi-Fakhari","year":"2021","unstructured":"Ebrahimi-Fakhari D, Stires G, Hahn E, Krueger D, Franz DN. Prenatal sirolimus treatment for rhabdomyomas in tuberous sclerosis. Pediatr Neurol. 2021;125:26\u201331. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.09.014.","journal-title":"Pediatr Neurol"},{"key":"3780_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.heliyon.2023.e16980","volume":"9","author":"N Jin","year":"2023","unstructured":"Jin N, Wu Y, Meng Q, Luo Q. Prenatal diagnosis of tuberous sclerosis complex: echocardiography, cranial magnetic resonance, and genetic testing of 40 cases with fetal cardiac tumors. Heliyon. 2023;9:1\u20138. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16980.","journal-title":"Heliyon"},{"key":"3780_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.case.2018.07.003","volume":"2","author":"C Patel","year":"2018","unstructured":"Patel C, Abraham S, Ferdman D. Rapid regression of prenatally identified intrapericardial giant rhabdomyomas with sirolimus. CASE (Phila, PA). 2018;2:258\u201361. https:\/\/doi.org\/10.1016\/j.case.2018.07.003.","journal-title":"CASE (Phila, PA)"},{"key":"3780_CR26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/uog.20196","volume":"53","author":"C Vachon-Marceau","year":"2019","unstructured":"Vachon-Marceau C, Guerra V, Jaeggi E, Chau V, Ryan G, Van Mieghem T. In-utero treatment of large symptomatic rhabdomyoma with sirolimus. Ultrasound Obstet Gynecol. 2019;53:420\u20131. https:\/\/doi.org\/10.1002\/uog.20196.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3780_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/pediatric15010020","volume":"15","author":"JC Will","year":"2023","unstructured":"Will JC, Siedentopf N, Schmid O, Gruber TM, Henrich W, Hertzberg C, et al. Successful prenatal treatment of cardiac rhabdomyoma in a fetus with tuberous sclerosis. Pediatr Rep. 2023;15:245\u201353. https:\/\/doi.org\/10.3390\/pediatric15010020.","journal-title":"Pediatr Rep"},{"key":"3780_CR28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1080\/15513815.2021.1948646","volume":"41","author":"A Dagge","year":"2022","unstructured":"Dagge A, Silva LA, Jorge S, Nogueira E, Rebelo M, Pinto L. Fetal tuberous sclerosis: sirolimus for the treatment of fetal rhabdomyoma. Fetal Pediatr Pathol. 2022;41:800\u20136. https:\/\/doi.org\/10.1080\/15513815.2021.1948646.","journal-title":"Fetal Pediatr Pathol"},{"key":"3780_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5468\/ogs.2019.62.4.280","volume":"62","author":"H Park","year":"2019","unstructured":"Park H, Chang CS, Choi SJ, Oh S, Roh CR. Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis. Obstet Gynecol Sci. 2019;62:280\u20134. https:\/\/doi.org\/10.5468\/ogs.2019.62.4.280.","journal-title":"Obstet Gynecol Sci"},{"key":"3780_CR30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/cpt.2563","volume":"112","author":"C Rodriguez-Antona","year":"2022","unstructured":"Rodriguez-Antona C, Savieo JL, Lauschke VM, Sangkuhl K, Dr\u00f6gem\u00f6ller BI, Wang D, et al. PharmVar GeneFocus: CYP3A5. Clin Pharmacol Ther. 2022;112:1159\u201371. https:\/\/doi.org\/10.1002\/cpt.2563.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03780-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03780-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03780-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:02:39Z","timestamp":1749484959000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03780-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3780"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03780-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This treatment was approved by the ethics committee of Aichi Children\u2019s Health and Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent about treatment and publication was obtained from the patient and her husband before sirolimus treatment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have indicated they have no conflict of interest relevant to this article to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"291"}}